Docoh
Loading...

IDXX Idexx Laboratories

IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, offering diagnostic and software products and services that deliver solutions and insights to practicing veterinarians around the world. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk and point-of-care and laboratory diagnostics for human medicine. Headquartered in Maine, IDEXX employs more than 9,000 people and offers products to customers in over 175 countries.

Company profile

Ticker
IDXX
Exchange
Website
CEO
Jonathan Jay Mazelsky
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
10393723

IDXX stock data

(
)

Calendar

12 Feb 21
13 Apr 21
31 Dec 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
26 Feb 21 Twigge Giovani Common Stock Option exercise Aquire M No No 67.85 3,227 218.95K 16,950
26 Feb 21 Twigge Giovani NQSO Common Stock Option exercise Dispose M No No 67.85 3,227 218.95K 0
25 Feb 21 James F Polewaczyk Common Stock Option exercise Aquire M No No 67.85 1,476 100.15K 19,903
25 Feb 21 James F Polewaczyk Incentive Stock Option (right-to-buy) Common Stock Option exercise Dispose M No No 67.85 1,476 100.15K 0
23 Feb 21 Ayers Jonathan W Common Stock Option exercise Aquire M No No 67.85 1,476 100.15K 654,213
23 Feb 21 Ayers Jonathan W Incentive Stock Option (right-to-buy) Common Stock Option exercise Dispose M No No 67.85 1,476 100.15K 0
23 Feb 21 Henderson Rebecca M Common Stock Sell Dispose S No No 513.4076 3,046 1.56M 14,696
23 Feb 21 Henderson Rebecca M Common Stock Option exercise Aquire M No No 160.28 3,046 488.21K 17,742
23 Feb 21 Henderson Rebecca M NQSO Common Stock Option exercise Dispose M No No 160.28 3,046 488.21K 0
22 Feb 21 Jonathan Jay Mazelsky Common Stock Option exercise Aquire M No No 67.85 1,475 100.08K 55,697

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

79.9% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 923 808 +14.2%
Opened positions 170 98 +73.5%
Closed positions 55 52 +5.8%
Increased positions 305 267 +14.2%
Reduced positions 304 293 +3.8%
13F shares
Current Prev Q Change
Total value 34.18B 27.05B +26.3%
Total shares 68.42M 67.34M +1.6%
Total puts 207.9K 123.3K +68.6%
Total calls 126.5K 161.1K -21.5%
Total put/call ratio 1.6 0.8 +114.7%
Largest owners
Shares Value Change
Vanguard 9.11M $4.55B -1.1%
BLK Blackrock 7.89M $3.94B +1.7%
STT State Street 3.56M $1.78B -3.2%
Bamco 3.11M $1.55B -4.1%
TROW T. Rowe Price 2.01M $1.01B -0.9%
Geode Capital Management 1.58M $787.39M +0.9%
Blair William & Co 1.48M $739.12M -2.1%
Alliancebernstein 1.39M $693.81M +2.5%
PFG Principal Financial Group Inc - Registered Shares 1.14M $568.74M -4.1%
BEN Franklin Resources 1.14M $568.49M +10.3%
Largest transactions
Shares Bought/sold Change
Norges Bank 679.88K +679.88K NEW
Carillon Tower Advisers 282.56K +267.61K +1790.0%
IVZ Invesco 953.49K +228.4K +31.5%
Durable Capital Partners 199.95K -183.11K -47.8%
MS Morgan Stanley 385.27K +155.83K +67.9%
Bank Julius Baer & Co. Ltd, Zurich 161.42K +154.59K +2265.1%
MN Manning & Napier 158.08K +154.23K +4000.7%
Citadel Advisors 31.65K -150.91K -82.7%
Lord, Abbett & Co. 339.18K +148.26K +77.7%
ATAC Neuberger Berman 954.75K -142.53K -13.0%

Financial report summary

?
Management Discussion
  •     Market Trends and COVID-19 Pandemic Impact. The primary impacts of the COVID-19 pandemic have been seen in our CAG business. While veterinary care is widely recognized as an “essential” service, stay-at-home policies deployed to combat the spread of COVID-19 constrained visits to veterinary practices significantly in late March 2020 through early April 2020, pressuring diagnostic testing volumes. Restrictions on sales professionals’ access to veterinary clinics also contributed to deferrals on new CAG instrument placements.
  •     As stay-at-home policies were relaxed, there was a sharp rebound in clinical visit activity which accelerated through the second quarter of 2020, and continued through the second half of 2020. Weekly U.S. companion animal practice data showed improvement in same-store clinical visits trends since mid-April 2020 and solid CAG market momentum has continued in early 2021.
  •     Companion animal market improvement trends globally have supported a strong recovery in demand for CAG diagnostic products and services. Global CAG Diagnostics recurring revenues declined approximately 16% in April 2020, followed by increases of approximately 8% in May 2020, 30% in June 2020, 24% in July 2020, and approximately 20% for the remainder of the third and fourth quarter of 2020.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: aim, antibody, appealing, array, Asha, Asian, beach, Bead, Brexit, career, caregiving, charitable, coach, coaching, combat, conflicting, contributor, Cooperation, correspondingly, Cosmetic, court, cultivating, deep, defend, defendant, DEI, delete, deployed, dispute, distancing, donation, dynamic, easy, EEA, emotional, encourage, encouraging, enrich, entrepreneurial, ergonomic, EUA, EURIBOR, female, foundation, freight, grace, grown, Heard, incorrect, incurrence, indirectly, invalidated, Islander, Justice, lifestyle, lockdown, lookback, Magnetic, magnitude, merit, Mindray, momentum, motivate, Native, noncompliance, nucleic, passed, passionate, plaintiff, professional, progression, pursue, quantification, question, rebound, rebuilding, regular, relaxed, relief, resumed, revocation, sharp, showed, SmartFlow, solid, speaker, spirit, steadfast, stricter, successor, suspended, taxation, TCA, timeframe, tomorrow, trial, underrepresented, vast, vigorously, voluntary, Waiver, warned, Weekly, women
Removed: adjacent, adrenal, aid, air, alanine, albumin, alkaline, alpaca, ALT, aminotransferase, Android, annualized, antigen, asserting, assumption, authority, band, BEAT, BeeFree, binding, biomarker, boarding, borrow, camel, cargo, CDOR, centrifuge, Choice, collaborate, collaboration, collectability, collected, College, consult, contaminated, converting, creatinine, cytometry, deducted, discontinuance, dolphin, dry, engineered, equine, ewingii, exchanged, facial, FDII, feature, ferret, fifteen, franc, gerbil, German, GILTI, goat, guinea, hamster, hookworm, identify, impedance, infected, interface, interpret, intervention, intestinal, kidney, launch, leasing, legally, Leipzig, Lepto, liver, living, llama, Ludwigsburg, mandatory, metering, mini, Missouri, Morgan, newest, newly, November, NT, nucleated, obtained, onset, optical, Parvo, passage, PetChek, PetDetect, phenobarbital, phosphatase, pig, positioning, premier, prepackaged, prohibitive, protein, rabbit, reclassification, refinanced, relying, renal, renovation, revaluation, roundworm, securely, sheep, simultaneously, slightly, SmartService, soil, soluble, strategically, stretch, supportable, territorial, thyroid, thyroxine, tract, traditionally, Tulane, UNAUDITED, unavailable, uncommitted, undiagnosed, undistributed, upgrade, user, utility, VPM, waterborne, whipworm, yield

Patents

GRANT
Utility
Methods, devices, kits and compositions for detecting roundworm, whipworm and hookworm
9 Mar 21
Methods, devices, kits and compositions for detecting the presence or absence of one or more helminthic coproantigens in a sample are disclosed herein.
GRANT
Utility
Method and device for detecting bacteria and determining the concentration thereof in a liquid sample
9 Feb 21
A method for detecting bacteria and determining the concentration thereof in a liquid sample includes the steps of taking an optical section through a container holding a volume of the liquid sample at a predetermined field of view and at a predetermined focal plane depth or angle and after a period of time has elapsed to allow non-bacteria in the sample to settle to the bottom of the container.
GRANT
Utility
Flow cytometer, laser optics assembly thereof, and methods of assembling the same
9 Feb 21
A flow cytometer, laser optics assembly thereof, and methods of assembling the same are provided.
APP
Utility
Animal Cage-Sample Collection Apparatus
4 Feb 21
Embodiments disclosed are directed to apparatuses, systems, and methods for the collection and sampling of agents (including organisms and pathogens) to determine the health of an animal colony.
APP
Utility
Lateral Flow Assay Reader Based on Human Perception and Method Relating Thereto
28 Jan 21
An instrument for reading a lateral flow assay device by detecting color changes based on human perception includes an optics module having a camera, a signal processor, a storage memory and a comparator circuit.